Depletion of Natural Killer Cells improve cholestasis in a murine model of primary biliary cholangitis

Abstract Background and Objective: The aim of this study is to investigate the role of NK cells and their phenotypes in xenobiotic induced murine model of primary biliary cholangitis (PBC)by eliminating NK cells. Methods: C57BL/6 female mice were immunized with 2OA-BSA and poly I:C to develop the murine model of PBC. Serologic, histologic, and immunologic testing of PBC mice were analyzed by depleting NK cells with ASGM1 before (ASGM1+PBC group) or after immunization (PBC+ASGM1 group). The proportions of NK cells, CD62L+NK cells, CD4+, and CD8+T in liver were analyzed. Results: ALT, AST and ALP in PBC mice was increased. In contrast to PBC mice, AST in ASGM1+PBC group was decreased. Moreover, TBIL was decreased in PBC+ASGM1 group. Notably, ALP and titer of AMA in mice treated with ASGM1 was decreased when compared with PBC mice. Comparing with HC, ASGM1+PBC or PBC+ASGM1 group mice, the ratio of CD4+T cells in liver declined in PBC mice. In comparison to HC and ASGM1+PBC group mice, the ratio of CD4+/CD8+T cells in PBC mice was lower. The frequency of CD62L+NK cells in the liver of PBC mice increased. However, there was no significant difference in histological scores among ASGM1+PBC, PBC+ASGM1 and PBC mice. Conclusions: Eliminating NK cells could reduce the degree of cholestasis and improve the immune imbalance. NK cells were functionally involved in pathogenesis and disease progression, especially CD62L+NK cells in liver might aggravate the progression of PBC..

Medienart:

Preprint

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

ResearchSquare.com - (2024) vom: 08. Apr. Zur Gesamtaufnahme - year:2024

Sprache:

Englisch

Beteiligte Personen:

Liu, Bin [VerfasserIn]
Liu, Zhaoyang [VerfasserIn]
Liu, Qixuan [VerfasserIn]
zhao, chenyang [VerfasserIn]
Zang, Bo [VerfasserIn]
She, Chunhui [VerfasserIn]
yang, Yifei [VerfasserIn]
Han, Yibing [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

570
Biology

doi:

10.21203/rs.3.rs-2978477/v1

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XRA039774953